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Background and purpose of the study: The hypotensive activity of the essential oil of Mentha x villosa and its
main constituent, the monoterpene rotundifolone, have been reported. Therefore, our objective was to evaluate
the vasorelaxant effect of monoterpenes found in medicinal plants and establish the structure-activity relationship
of rotundifolone and its structural analogues on the rat superior mesenteric artery.
Methods: Contractions of the vessels were induced with 10 μM of phenylephine (Phe) in rings with endothelium.
During the tonic phase of the contraction, the monoterpenes (10-8 - 10-3, cumulatively) were added to the organ
bath. The extent of relaxation was expressed as the percentage of Phe-induced contraction.
Results: The results from the present study showed that both oxygenated terpenes (rotundifolone, (+)-limonene
epoxide, pulegone epoxide, carvone epoxide, and (+)-pulegone) and non-oxygenated terpene ((+)-limonene)
exhibit relaxation activity. The absence of an oxygenated molecular structure was not a critical requirement for the
molecule to be bioactive. Also it was found that the position of ketone and epoxide groups in the monoterpene
structures influence the vasorelaxant potency and efficacy.
Major conclusion: The results suggest that the presence of functional groups in the chemical structure of
rotundifolone is not essential for its vasorelaxant activity.
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The essential oils are natural products extracted from
species of aromatic plants and exhibit a variety of bio-
logical properties [1-6]. These effects are attributed
mainly to the terpenes, which are the major chemical
components of these oils. The cardiovascular activity of
essential oils has been reported [7-10]. Some studies
showed that the main chemical components of these oils
are bioactive [7,10-12].
The antihypertensive activity of some plants also has
been related to the presence of terpenes. Extracts and
diterpenoids of Salvia species have shown cardiovascular
activity, such as ferruginol and 7-oxo-abieta-9,12,14-triene
[13]. In another work, in normotensive anaesthetised rats,
the cardiovascular effect of the essential oil of Mentha x
villosa and its main constituent, rotundifolone, suggests* Correspondence: damiao_desousa@yahoo.com.br
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distribution, and reproduction in any mediumthat hypotensive activity may result from its vasodilatory
effects directly upon vascular smooth muscle [11]. Add-
itional studies showed that the hypotensive activity of the
monoterpene rotundifolone is related to decrease in heart
rate and peripheral vascular resistance, probably via non-
selective muscarinic receptor stimulation [14].
For these reasons, it appeared possible that terpenes
found in essential oils could also have cardiovascular ac-
tivity. Therefore, our objective was to verify the potential
vasorelaxant effect of representative monoterpenes
present in medicinal plants and to determine the rela-
tionship between the chemical structure of rotundifo-
lone and its vasorelaxant activity to understand the
influence of the functional groups present in this mono-
terpene. Therefore, we assessed p-menthane monoter-
penes containing ketone groups and/or epoxy in
different positions in the chemical structure. In addition,
a monoterpene that does not contain these functional
groups was also evaluated.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Chemical structures of the monoterpenes used in this
study.
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Chemicals and solutions
(+)-Limonene epoxide was prepared via oxidation of
(+)-limonene with m-chloroperoxybenzoic acid [15].
Pulegone epoxide [16] and carvone epoxide [17] were
prepared via oxidation of (+)-pulegone and (−)-carvone,
respectively, using hydrogen peroxide in alkaline
medium as previously described. (+)-Pulegone was pur-
chased from Aldrich. (+)-Limonene was purchased from
company Dierberger Óleos Essenciais S.A., Barra Bonita,
Brazil. Rotundifolone was isolated from the essential oil
of Mentha x villosa using a previously described proced-
ure [18]. The purity of test compounds was higher than
95%. L-Phenylephrine chloride (Phe) and acetylcholine
chloride (Ach) were purchase from Sigma (Sigma Chem-
ical Co., USA). In the preparation of the stock solutions,
the monoterpenes were diluted in Tyrode/cremophor
(0.15% v/v) solution. Phe and Ach were diluted or in
Tyrode solutions only. All stock solutions were main-
tained at 0°C and diluted to the desired concentration,
when necessary. Cremophor (Sigma Chemical Co., USA)
in used concentrations showed no effect on control
experiments (data not shown).
(Composition of Tyrode’s solution in mM: NaCl 158.3,
KCl 4.0, CaCl2 2.0, NaHCO3 10.0, C6H12O6 5.6, MgCl2
1.05 and NaH2PO4 0.42).
Animals
Male Wistar normotensive rats (200 – 300 g) were
obtained from colonies maintained in the Department of
Physiology, Federal University of Sergipe, Sergipe, Brazil.
They were maintained in a large cage under controlled
conditions of temperature and lighting (lights on: 06:00–
18:00 h), fed with rodent diet and tap water ad libtum.
All procedures were approved by the Animal Research
Ethics Committee of the Universidade Federal de Ser-
gipe, Brazil (Protocol number 15/2009) and were in
compliance with the Guide for the Care and Use of La-
boratory Animals published by the US National Insti-
tutes of Health (NIH publication 85–23, revised 1996).
Pharmacological assays
The tissue preparation was performed as described in
Menezes et al. [19]. Rats were sacrificed by exsanguin-
ation under ether aesthesia and superior mesenteric ar-
tery was removed, cleaned from connective and fat
tissues and sectioned in rings (1 – 2 mm). These rings
were suspended in organ baths containing 10 mL of Tyr-
ode’s solution, gassed with carbogen and maintained at
37°C under a resting tension of 0.75 g for 60 min
(stabilization period). The isometric tension was
recorded through a force transducer (Letica, Model
TRI210, Italy) coupled to an amplifier-recorder (AVS,
Brazil). Endothelium functionality of the rings wasassessed by the ability of Ach (10 μM) to induce more
than 70% relaxation of Phe (10 μM) tonus.
After verify the functionality of vascular endothelium,
contractions of the vessels were induced with 10 μM Phe
in rings with endothelium. During the tonic phase of the
contraction, the monoterpenes rotundifolone, (+)-limonene
epoxide, pulegone epoxide, carvone epoxide, (+)-pulegone
and (+)-limonene (10-8 - 10-3, cumulatively) were added to
the organ bath. The extent of relaxation was expressed as
the percentage of Phe-induced contraction.
Statistic analysis
Values were expressed as the mean ± SEM. The results
were analyzed with one-way ANOVA followed by Bon-
ferroni post-test. The potency was expressed as pD2
value (negative logarithm of molar concentration pro-
ducing the half maximum effect - Emax) of in vitro
experiments were obtained by non-linear regression.
All procedures were performed by using Graph Pad
Prism 3.02™.
Results and discussion
Several studies have reported pharmacological effects
of essential oils on the rat cardiovascular system
[9-11,20,21]. However, there are few studies on bioactive
compounds that contribute to the pharmacological ac-
tivity of these oils. We report in this comparative study
the findings on the vasorelaxant activity of six monoter-
penes (Figure 1): rotundifolone (having α,β-unsaturated
ketone and endocyclic epoxide groups), limonene epox-
ide (having only an epoxide group), pulegone epoxide
(having ketone and exocyclic epoxide groups), carvone
epoxide (having ketone and endocyclic epoxide groups),
(+)-pulegone (having an α,β-unsaturated ketone), and
(+)-limonene (non-oxygenated terpene).
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ketone and epoxide groups in the molecular structure
was performed by comparing the rotundifolone (1) with
the pulegone epoxide (2) and carvone epoxide (3). The
rotundifolone showed a vasorelaxant effect in rat mesen-
teric artery more potent than carvone epoxide (p < 0.01),
suggesting that the position of the ketone group influ-
ences this spasmolytic property. In addition, the
pharmacological activity of rotundifolone was lower than
the pulegone epoxide (p < 0.05). This result demonstrates
that the position of epoxide group in the p-menthane
structure alters the pharmacological activity. The experi-
mental data also showed that the pulegone epoxide
exhibit more significant vasorelaxant activity in compari-
son to carvone epoxide (p < 0.001), indicating that the
exocyclic epoxide group contributes more to the
pharmacological effect than the endocyclic epoxide
group. These results confirm that the position of epoxide
and ketone functional groups in molecules change the
vasorelaxant activity. Comparing rotundifolone with
(+)-limonene (4), these compounds showed equipotent
vasorelaxant activity (p > 0.05). The spasmolytic activity
of (+)-limonene shown in this study demonstrates that
non-oxygenated terpenes present in cardioactive essen-
tial oils may contribute to this activity. (+)-Limonene ep-
oxide (5) and (+)-pulegone (6) presented vasorelaxant
activity below 50%, so it was not allowed to calculate
their pD2 (Table 1).
Similarly, the effectiveness of the tested compounds
was investigated by comparing their maximum effects.
The rotundifolone showed a higher pharmacological ef-
fect than (+)-pulegone (p <0.05). While (+)-limonene
was more effective than (+)-pulegone (p <0.01) and lim-
onene epoxide (p <0.01). Carvone epoxide exhibited a
maximum effect of relaxation greater than pulegone ep-
oxide (p <0.01), (+)-pulegone (p <0.001), and limonene
epoxide (p <0.001).Table 1 Values of pD2 and Emax obtained of
concentration-response curves to monoterpenes in
isolated rings of rat superior mesenteric artery with
functional endothelium pre-contracted with Phe (10 μM)
Monoterpenes N pD2 Emax
Rotundifolone (1) 4 5.1 ± 0.2 71.7 ± 6.2
Pulegone epoxide (2) 4 6.3 ± 0.3a,c 55.5 ± 3.0
Carvone epoxide (3) 4 3.4 ± 0.3e 99.8 ± 18.7**,***
(+)-Limonene (4) 4 5.1 ± 0.1 84.2 ± 4.1##
(+)-Limonene epoxide (5) 4 — 34.0 ± 2.0
(+)-Pulegone (6) 4 — 30.3 ± 2.3*
N = Number of experiments; pD2 – Potency; Emax – Maximum Effect;
ap< 0.05
vs rotundifolone and (+)-limonene; cp< 0.001 carvone epoxide, and ep< 0.01 vs
rotundifolone and (+)-limonene. *p< 0.05 vs rotundifolone, ***p< 0.001 vs
(+)-pulegone and limonene epoxide; **p< 0.01 vs pulegone epoxide, and ##
p< 0.01 vs (+)-pulegone and limonene epoxide.It is described in the literature that the monoterpene
terpinen-4-ol produces hypotensive effect in rats.
Terpinen-4-ol is the main constituent of the essential
oil of Alpinia zerumbet (Pers.) B. L. Burtt. & R. M.
Sm. (Zingiberaceae). Lahlou et al. [12] proved that the
hypotensive effects of the essential oil of Alpinia
zerumbet are partially attributed to the actions of ter-
pinen-4-ol, which was more potent than this oil. In
another study, Barbosa-Filho et al. [22] showed
that the essential oils from stem and root of the plant
Ocotea duckei have hypotensive activity. The main
chemical constituents of these oils are the terpene
β-eudesmol and elemol, respectively. These reports,
together with our findings, demonstrate the importance
of this natural chemical class as good candidates for
antihypertensive drugs.
Furthermore, studies have demonstrated that some of
these terpenes exhibit depressant properties in other or-
ganic systems. Sadraei et al. [4] and Camara et al. [5]
showed that both, (+)-α- and (−)-β-pinene, relax rat and
guinea-pig ileum, respectively. Other studies have shown
that (±)-linalool promotes spasmolytic effect in guinea-
pig ileum mediated by cAMP [23], and recently
Tanida et al. [24] demonstrated that the inhalation of
(±)-linalool reduces the blood pressure mediated by the
central nervous system in rats. Therefore, the
hypotensive activity could originate from vasodilatory
effects induced by these compounds. This possible
mechanism of action was studied in citronellol, which
lowers blood pressure by a direct effect on the vascular
smooth muscle leading to vasodilation [25].
The biotransformation of some compounds tested is
known. For example, (+)-limonene is biotransformed to
several metabolites, such as (+)-limonene epoxide, car-
vone, and perillyl alcohol [26,27]. (+)-Limonene epoxide is
one of the bioactive compounds of the present study. Car-
vone has ketone group which is present in the chemical
structure of carvone epoxide, another evaluated com-
pound. The monoterpene perillyl alcohol has hypotensive
activity [28]. Pulegone also produces bioactive metabolites,
such as menthol [29] which has vasorelaxant activity [30].
Therefore, the metabolites of (+)-limonene, pulegone, and
other tested compounds should contribute to their vasore-
laxant activity. In addition, the tested compounds must
act by different mechanisms of action. In fact, monoter-
pene alcohols, aldehydes, ethers, and hydrocarbons show
effects on the cardiovascular system via vasorelaxation,
decreased heart rate or hypotension, among others [31].
The mechanisms of action of these compounds should be
related to their metabolites.
Conclusion
The results from the present study showed that both
oxygenated terpenes and hydrocarbon terpene exhibit
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lecular structure was not a critical requirement for the
molecule to be bioactive. The position of ketone and ep-
oxide groups in the p-menthane structure influences the
vasorelaxant potency and efficacy. Therefore, these func-
tional groups contribute to the vasorelaxant activity of
rotundifolone.
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